Buchfelder M, Zhao Y, Schlaffer SM (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 109
Pages Range: 77-81
Journal Issue: 1
DOI: 10.1159/000497331
While in the past surgery for prolactinomas was a competitive option to medical treatment with dopamine agonists, to date the indications for operations are restricted to only a few specific situations. However, if a patient is intolerant to medical treatment or if the drugs are not sufficiently effective in terms of lowering prolactin levels or tumor shrinkage, surgery should always be considered. In microprolactinomas, operations can achieve excellent prolactin normalization rates. In tumors difficult to treat, the combination of surgical tumor resection and long-term medical treatment supports better control of the disease. The individual indications, results, techniques, and complications of operations for prolactinomas are briefly reviewed in this paper.
APA:
Buchfelder, M., Zhao, Y., & Schlaffer, S.-M. (2019). Surgery for Prolactinomas to Date. Neuroendocrinology, 109(1), 77-81. https://doi.org/10.1159/000497331
MLA:
Buchfelder, Michael, Yining Zhao, and Sven-Martin Schlaffer. "Surgery for Prolactinomas to Date." Neuroendocrinology 109.1 (2019): 77-81.
BibTeX: Download